Current filters:  
Healthcare
Food and Drugs Law
Australia
Colin Biggers & Paisley
For therapeutic use, cannabis products may be available over-the-counter in Australian pharmacies without a prescription.
Brazil
Venturini IP
On March 11, 2020, the World Health Organization characterized COVID-19, a disease caused by the new coronavirus (scientifically called SARS-CoV-2), as a pandemic.
Canada
Torys LLP
The Patented Medicine Prices Review Board (PMPRB) has announced a delay in the coming-into-force of the amended Patent Medicines Regulations (the Regulations) to January 1, 2021.
Torys LLP
In a recent decision, the Federal Court of Appeal overturned the Federal Court's order that the trial of common issues in separate actions under the Patented Medicine (Notice of Compliance) Regulations involving...
MLT Aikins LLP
On May 5, 2020, the Government of Canada announced an aid package for Canadian farmers and the agri-food sector in response to the far-reaching impacts of the COVID-19 on the agriculture industry.
Clark Wilson LLP
Like virtually every person, family, and business around the world, the Federal Court of Canada was forced to suspend its normal operations this year as a result of the global COVID19 pandemic.
Fasken
As of July 1, 2020, the pharmaceutical industry will be able to distribute non-prescription or over-the-counter drugs ("OTCs") as well as natural health products ("NHPs") as samples to designated healthcare professionals.
Smart & Biggar
Further to our last update on the amendments to the Patented Medicines Regulations and related Guidance, the Patented Medicine Prices Review Board (PMPRB) has today announced that...
Borden Ladner Gervais LLP
The COVID-19 pandemic has created unprecedented demand for certain health products, most notably personal protective equipment, diagnostic tests and hand sanitizer.
Smart & Biggar
The first decision considering the scope and meaning of the provisions in the Patent Act relating to Certificates of Supplementary Protection (CSPs) has now been released.
China
Kangxin
요약:본 문에서 구체적인 안례를 통해 중국에서 중의약영역 특허출원시 미용방법의 청구항 수정방식을 대해 분석하려고 한다.
Czech Republic
Kinstellar
On 11 May 2020, the Czech government approved a bill amending the Act on Addictive Substances (the "Bill"). The purpose of the Bill is to expand the possibilities for cultivating cannabis for medical
India
Obhan & Associates
The ethics of intellectual property has always been a highly debated issue, and spans a range of issues, not least around what kind of patentable subject matter can be regarded as ethically permissible.
Singh & Associates
This segment of the newsletter shares recent information related to regulatory reforms from Healthcare and Pharmaceutical sectors in India.
Singh & Associates
On January 28, 2020, National Pharmaceutical Pricing Authority (NPPA) fixed the pricing of 17 formulations under Drugs Prices Control Order (DPCO) 2013.
Singh & Associates
The union Health and Family Welfare Ministry has come out with a notification on implementation of Drugs and Cosmetics (Amendment) Rules, 2020, which holds marketers along with the manufacturers...
Singh & Associates
On February 07, 2020, the Central Drugs Standard Control Organization (CDSCO) directed the manufacturers of Fixed-Dose Combination (FDCs) who are already holding the licenses from state drug...
Khurana and Khurana
Telemedicine basically means "healing at a distance". It is great for both patients and medical assistance provider. That there is no one definitive definition of telemedicine – a 2007 study...
Khurana and Khurana
Gliead is rapidly working to fight with this outbreak of novel COVID-19. Remdesivir is a potential drug for the treatment for COVID-19
S.S. Rana & Co. Advocates
The sudden outbreak of the novel COVID 19 virus has left a damaging impact all over the globe.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media